NDC 67850-140

Asclera

Polidocanol

Asclera is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Methapharm, Inc. The primary component is Polidocanol.

Product ID67850-140_ed77119d-3a51-48d9-ad3f-d5320103ed6f
NDC67850-140
Product TypeHuman Prescription Drug
Proprietary NameAsclera
Generic NamePolidocanol
Dosage FormInjection, Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2010-06-01
Marketing CategoryNDA /
Application NumberNDA021201
Labeler NameMethapharm, Inc
Substance NamePOLIDOCANOL
Active Ingredient Strength0 g/mL
Pharm ClassesSclerosing Agent [EPC],Sclerosing Activity [MoA],Vascular Sclerosing Activity [PE]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 67850-140-05

2 mL in 1 AMPULE (67850-140-05)
Marketing Start Date2022-02-01
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Asclera" or generic name "Polidocanol"

NDCBrand NameGeneric Name
46783-121AscleraPOLIDOCANOL
46783-221AscleraPOLIDOCANOL
67850-140AscleraPOLIDOCANOL
67850-141AscleraPOLIDOCANOL
60635-107Varithenapolidocanol
60635-111Varithenapolidocanol
60635-118Varithenapolidocanol
60635-123Varithenapolidocanol
60635-133Varithenapolidocanol

Trademark Results [Asclera]

Mark Image

Registration | Serial
Company
Trademark
Application Date
ASCLERA
ASCLERA
90035122 not registered Live/Pending
Chemische Fabrik Kreussler & Co. GmbH
2020-07-03
ASCLERA
ASCLERA
77840002 3842974 Dead/Cancelled
Chemische Fabrik Kreussler & Co. GmbH
2009-10-02

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.